Century Therapeutics Inc (IPSC)
2.99
-0.14
(-4.47%)
USD |
NASDAQ |
May 17, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Total Assets (Quarterly): 348.51M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 348.51M |
| December 31, 2023 | 360.69M |
| September 30, 2023 | 397.55M |
| June 30, 2023 | 417.16M |
| March 31, 2023 | 456.23M |
| December 31, 2022 | 486.54M |
| September 30, 2022 | 511.75M |
| Date | Value |
|---|---|
| June 30, 2022 | 532.58M |
| March 31, 2022 | 550.31M |
| December 31, 2021 | 437.38M |
| September 30, 2021 | 469.72M |
| June 30, 2021 | 495.63M |
| March 31, 2021 | 286.06M |
| December 31, 2020 | 106.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
106.78M
Minimum
Dec 2020
550.31M
Maximum
Mar 2022
418.35M
Average
446.80M
Median
Total Assets (Quarterly) Benchmarks
| Verastem Inc | 123.54M |
| Entero Therapeutics Inc | 6.883M |
| Gritstone Bio Inc | 137.21M |
| Allogene Therapeutics Inc | 586.35M |
| Mirum Pharmaceuticals Inc | 651.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 170.62M |
| Shareholders Equity (Quarterly) | 177.88M |
| Current Ratio | 12.44 |
| Net Debt Paydown Yield | 0.76% |